Patrick Blake Buys 3,097 Shares of Mayne Pharma Group Limited (ASX:MYX) Stock
Patrick Blake Buys 3,097 Shares of Mayne Pharma Group Limited (ASX:MYX) Stock
Mayne Pharma Group Limited (ASX:MYX – Get Rating) insider Patrick Blake bought 3,097 shares of the firm's stock in a transaction on Thursday, April 13th. The stock was acquired at an average cost of A$4.07 ($2.73) per share, with a total value of A$12,592.40 ($8,451.28).
Mayne Pharma Group Limited（ASX: MYX — 获取评级）内部人士帕特里克·布莱克在4月13日星期四的一笔交易中购买了该公司3,097股股票。该股票的收购平均成本为每股4.07澳元（2.73美元），总价值为12,592.40澳元（8,451.28美元）。
Mayne Pharma Group Price Performance
梅恩制药集团的价格表现
The company has a quick ratio of 0.62, a current ratio of 1.45 and a debt-to-equity ratio of 10.18.
该公司的速动比率为0.62，流动比率为1.45，债务与权益比率为10.18。
About Mayne Pharma Group
关于梅恩制药集团
(Get Rating)
（获取评分）
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products.
Mayne Pharma Group Limited是一家专业制药公司，在澳大利亚、新西兰、美国、加拿大、欧洲和亚洲生产和销售品牌和仿制药产品。该公司通过四个部门运营：Metrics合同服务、国际、品牌产品和组合产品。
Read More
阅读更多
- Finding New Technology to Invest in: A Guide
- Genuine Parts Company Is Genuinely A Good Buy
- Healthcare Sector: Overview and Keys to Investing
- Can D.R. Horton Shares Raise The Roof, Or Is This The Ceiling?
- American Express Growth Riding On Joyful Consumer Spending
- 寻找可供投资的新技术：指南
- 正品零件公司确实是个不错的选择
- 医疗保健行业：概述和投资关键
- D.R. Horton 的股票能否抬高屋顶，还是这是上限？
- 美国运通的增长取决于愉快的消费者支出
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
接收梅恩制药集团每日的新闻和收视率 -在下面输入您的电子邮件地址，以通过Marketbeat.com的免费每日电子邮件时事通讯接收Mayne Pharma Group及相关公司最新新闻和分析师评级的简明每日摘要。